Clover Corporation Limited
A$1.00+A$0.01 (+0.5%)
Clover Corporation Limited’s quoted price sits in the upper half of its reported 52-week range, 14.53% below the high.
ASX · BXN.AX · AUD
Stock price, earnings
Quote as of Jul 6, 2026, 06:10 AM UTC. Cached market data; not a live quote.
One-year closing-price history · AUD. Historical prices are not a forecast.
Bioxyne Limited’s quoted price sits in the upper half of its reported 52-week range, 15.45% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Bioxyne Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Headquartered in Sydney, Australia, Bioxyne Limited is a life sciences and health company established in 1998. The firm dedicates itself to the research, development, marketing, and distribution of nutritional supplements and beauty products. Its operations are divided into wholesale and direct sales segments, reaching customers online, through partners, and directly across the United States and Asia. Bioxyne's diverse product line includes functional foods and cosmetic solutions, notably Progastrim for digestive and immune wellness, Progastrim plus Vitamin C for cold symptom relief, and proTract, specifically formulated for infant eczema (atopic dermatitis).
Latest available per-share figures in AUD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:35 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
A$1.00+A$0.01 (+0.5%)
Clover Corporation Limited’s quoted price sits in the upper half of its reported 52-week range, 14.53% below the high.
NZ$0.24-NZ$0.01 (-2.04%)
New Zealand King Salmon Investments Limited’s quoted price sits in the upper half of its reported 52-week range, 5.88% below the high.
A$0.82-A$0.01 (-1.21%)
EDU Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 33.74% below the high.
A$0.69-A$0.01 (-0.72%)
LARK Distilling Co. Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.51% below the high.
A$0.28A$0.00 (0.0%)
Farm Pride Foods Limited’s quoted price sits in the upper half of its reported 52-week range, 14.06% below the high.
A$0.12A$0.00 (0.0%)
Noumi Limited’s quoted price sits in the upper half of its reported 52-week range, 12.73% below the high.
A$0.05A$0.00 (0.0%)
Maggie Beer Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 57.5% below the high.
A$0.02A$0.00 (0.0%)
Australian Dairy Nutritionals Limited’s quoted price sits in the lower half of its reported 52-week range, 60.98% below the high.